Skip to main content
SpringerLink
Log in

Pulmonary Hypertension in Cardiac Surgery

  • Chapter
  • First Online:
Anesthesia in High-Risk Patients

Abstract

Pulmonary hypertension is a high-risk situation for anesthesia, specifically during cardiac surgery or transplantation. Three major pathways (the prostacyclin, endothelin, and nitric oxide (NO) pathways) have been established contributing to recent significant progresses in specific medical treatments, which have changed the prognosis. Recommendations for drugs are also related to the update classification of a complex disease. Nevertheless, PH associated with left heart failure, frequently observed in cardiac surgery, has been more explored only recently, like “combined” post- and precapillary PH (Cpc-PH), and need more evaluation for adequate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gomez CM, Palazzo MG. Pulmonary artery catheterization in anaesthesia and intensive care. Br J Anaesth. 1998;81:945–56.

    Article  CAS  PubMed  Google Scholar 

  2. Naeije R, Brimioulle S, Dewachter L. Biomechanics of the right ventricle in health and disease (2013 Grover Conference series). Pulm Circ. 2014;4:395–406.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34–41.

    Article  PubMed  Google Scholar 

  4. Fang JC, DeMarco T, Givertz MM, Borlaug BA, Lewis GD, Rame JE, et al. World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2012;31:913–33.

    Article  PubMed  Google Scholar 

  5. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol. 2013;62(25 Suppl):100–8.

    Article  Google Scholar 

  6. Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiéry JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016;37:942–54.

    Article  PubMed  Google Scholar 

  7. Kanwar MK, Thenappan T, Vachiéry JL. Update in treatment options in pulmonary hypertension. J Heart Lung Transplant. 2016;15:695–703.

    Article  Google Scholar 

  8. Zhuang XD, Long M, Li F, Hu X, Liao XX, Du ZM. PDE5 inhibitor sildenafil in the treatment of heart failure: a meta-analysis of randomized controlled trials. Int J Cardiol. 2014;172:581–7.

    Article  PubMed  Google Scholar 

  9. Galiè N, Ghofrani AH. New horizons in pulmonary arterial hypertension therapies. Eur Respir Rev. 2013;22:503–14.

    Article  PubMed  Google Scholar 

  10. Girard C, Bastien O, Estanove S, Lehot JJ. Inhaled nitric oxide in anesthesia and intensive care. Ann Fr Anesth Reanim. 1997;16:30–46.

    Article  CAS  PubMed  Google Scholar 

  11. Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med. 2003;29:1996–2003.

    Article  PubMed  Google Scholar 

  12. Kerbaul F, Brimioulle S, Rondelet B, Dewachter C, Hubloue I, Naeije R. How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med. 2007;175:846–50.

    Article  CAS  PubMed  Google Scholar 

  13. Kulkarni A, Singh TP, Sarnaik A, Walters HL, Delius R. Sildenafil for pulmonary hypertension after heart transplantation. J Heart Lung Transplant. 2004;23:1441–4.

    Article  PubMed  Google Scholar 

  14. Kim SY, Shim JK, Shim YH, Hong SW, Choi KH, Kwak YL. Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery. J Heart Valve Dis. 2010;19:333–40.

    PubMed  Google Scholar 

  15. Rondelet B, Kerbaul F, Motte S, van Beneden R, Remmelink M, et al. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation. 2003;107:1329–35.

    Article  CAS  PubMed  Google Scholar 

  16. Kerbaul F, Gariboldi V, Giorgi R, Mekkaoui C, Guieu R, et al. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure. Crit Care Med. 2007;35:1948–54.

    Article  CAS  PubMed  Google Scholar 

  17. Dewachter C, Dewachter L, Rondelet B, Fesler P, Brimioulle S, et al. Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure. Crit Care Med. 2010;38:1405–13.

    Article  PubMed  Google Scholar 

  18. Ghofrani HA, Galie N, Grimminger F, et al. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med. 2013;369:330–40.

    Article  CAS  PubMed  Google Scholar 

  19. Tedford RJ, Beaty CA, Mathai SC, Kolb TM, Damico R, et al. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension. J Heart Lung Transplant. 2014;33:289–97.

    Article  PubMed  Google Scholar 

  20. Grant AD, Smedira NG, Starling RC, Marwick TH. Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol. 2012;60:521–8.

    Article  PubMed  Google Scholar 

  21. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163–72.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Meyer S, McLaughlin VV, Seyfarth HJ, Bull TM, Vizza CD, Gomberg-Maitland M, et al. Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J. 2013;41:1302–7.

    Article  PubMed  Google Scholar 

  23. Pritts CD, Pearl RG. Anesthesia for patients with pulmonary hypertension. Curr Opin Anaesthesiol. 2010;23:411–6.

    Article  PubMed  Google Scholar 

  24. Zuckerman WA, Turner ME, Kerstein J, Torres A, Vincent JA, Krishnan U, et al. Safety of cardiac catheterization at a center specializing in the care of patients with pulmonary arterial hypertension. Pulm Circ. 2013;3:831–9.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bayat F, Aghdaii N, Farivar F, Bayat A, Valeshabad AK. Early hemodynamic changes after mitral valve replacement in patients with severe and mild pulmonary artery hypertension. Ann Thorac Cardiovasc Surg. 2013;19:201–6.

    Article  PubMed  Google Scholar 

  26. Kerbaul F, Rondelet B, Motte S, Fesler P, Hubloue I, et al. Isoflurane and desflurane impair right ventricular-pulmonary arterial coupling in dogs. Anesthesiology. 2004;101:1357–62.

    Article  CAS  PubMed  Google Scholar 

  27. Ewalenko P, Brimioulle S, Delcroix M, Lejeune P, Naeije R. Comparison of the effects of isoflurane with those of propofol on pulmonary vascular impedance in experimental embolic pulmonary hypertension. Br J Anaesth. 1997;79:625–30.

    Article  CAS  PubMed  Google Scholar 

  28. Kerbaul F, Bellezza M, Mekkaoui C, Feier H, Guidon C, et al. Sevoflurane alters right ventricular performance but not pulmonary vascular resistance in acutely instrumented anesthetized pigs. J Cardiothorac Vasc Anesth. 2006;20:209–16.

    Article  PubMed  Google Scholar 

  29. Galante D. Intraoperative management of pulmonary arterial hypertension in infants and children. Curr Opin Anaesthesiol. 2009;22:378–82.

    Article  PubMed  Google Scholar 

  30. Williams GD, Maan H, Ramamoorthy C, Kamra K, Bratton SL, et al. Perioperative complications in children with pulmonary hypertension undergoing general anesthesia with ketamine. Paediatr Anaesth. 2010;20:28–37.

    Article  PubMed  Google Scholar 

  31. Jiang L, Ding S, Yan H, Li Y, Zhang L, Chen X, et al. A retrospective comparison of dexmedetomidine versus midazolam for pediatric patients with congenital heart disease requiring postoperative sedation. Pediatr Cardiol. 2015;36:993–9.

    Article  PubMed  Google Scholar 

  32. Klotz S, Wenzelburger F, Stypmann J, Welp H, Drees G, Schmid C, Scheld HH. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant. Ann Thorac Surg 2006; 82: 1770–3.

    Google Scholar 

  33. Mikus E, Stepanenko A, Krabatsch T, Loforte A, Dandel M, et al. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. Eur J Cardiothorac Surg. 2011;40:971–7.

    PubMed  Google Scholar 

  34. Houston BA, Kalathiya RJ, Hsu S, Loungani R, Davis ME, et al. Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: a multi-center hemodynamic analysis. J Heart Lung Transplant. 2016;35:868–76.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Rush B, Biagioni BJ, Berger L, McDermid R. Mechanical ventilation outcomes in patients with pulmonary hypertension in the United States: a national retrospective cohort analysis. J Intensive Care Med. 2016. doi:10.1177/0885066616653926.

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesia and Critical Care, University Lyon I, Lyon, France

    Bastien Olivier M.D., Ph.D.

  2. National Agency of Biomedicine, 1 av Stade de France, 93212, Saint Denis la plaine, France

    Bastien Olivier M.D., Ph.D.

Authors
  1. Bastien Olivier M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bastien Olivier M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Anaesthesiology and Critical Care Medicine, Louis Pradel Hosp, Hospices Civils Lyon, Lyon, Rhône, France

    Jean-Luc Fellahi

  2. Service d'Anesthésie-Réanimation, Hôpital Nord, Marseille cedex 20, France

    Marc Leone

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Olivier, B. (2018). Pulmonary Hypertension in Cardiac Surgery. In: Fellahi, JL., Leone, M. (eds) Anesthesia in High-Risk Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-60804-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-60804-4_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-60803-7

  • Online ISBN: 978-3-319-60804-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation